P P. Van Balen
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
T-cell receptor repertoires against HLA class I-restricted minor histocompatibility antigens are highly diverse with a small subset of public clonotypes.
Journal: Journal for immunotherapy of cancer
Published: August 02, 2026
Long-term outcome of a DLI-based treatment strategy in patients with relapsed AML after TCD allogeneic stem cell transplantation is hampered by GvHD and late relapse.
Journal: Transplantation and cellular therapy
Published: June 02, 2026
Intravenous Lipopolysaccharide Challenge in Healthy Participants Reveals Pharmacodynamic Markers in Blood and Bone Marrow for Early-Phase Oncology Drug Development.
Journal: Clinical pharmacology and therapeutics
Published: December 20, 2025
Correction: Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion.
Journal: Frontiers in immunology
Published: May 28, 2025
DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantation.
Journal: Journal for immunotherapy of cancer
Published: October 26, 2024
Integrated care pathway for occupational pulmonary diseases.
Journal: Allergy
Published: February 15, 2024
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning.
Journal: Science advances
Published: November 24, 2023
Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation.
Journal: Frontiers in immunology
Published: November 08, 2023
Last Updated: 09/26/2026